vs
Forestar Group Inc.（FOR）与PTC THERAPEUTICS, INC.（PTCT）财务数据对比。点击上方公司名可切换其他公司
Forestar Group Inc.的季度营收约是PTC THERAPEUTICS, INC.的1.7倍（$273.0M vs $164.7M），Forestar Group Inc.净利率更高（5.6% vs -82.0%，领先87.6%），Forestar Group Inc.同比增速更快（9.0% vs -22.7%），PTC THERAPEUTICS, INC.自由现金流更多（$-36.6M vs $-157.1M），过去两年Forestar Group Inc.的营收复合增速更高（-9.6% vs -11.5%）
福雷斯特集团是一家住宅地块开发企业，总部位于得克萨斯州阿灵顿，业务覆盖美国21个州的51个市场。截至2020年12月31日的12个月内，该公司交付了11518块住宅地块，目前在纽约证券交易所上市，自2002年起就是美国规模最大的住宅建筑商D.R. Horton的控股子公司。
PTC Therapeutics是一家总部位于美国的制药企业，专注于开发口服小分子药物及基因疗法，通过靶向转录后调控机制调节基因表达，相关产品管线主要面向罕见病治疗领域，致力于满足相关疾病未被覆盖的临床治疗需求。
FOR vs PTCT — 直观对比
营收规模更大
FOR
是对方的1.7倍
$164.7M
营收增速更快
FOR
高出31.8%
-22.7%
净利率更高
FOR
高出87.6%
-82.0%
自由现金流更多
PTCT
多$120.5M
$-157.1M
两年增速更快
FOR
近两年复合增速
-11.5%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $273.0M | $164.7M |
| 净利润 | $15.4M | $-135.0M |
| 毛利率 | 20.1% | — |
| 营业利润率 | 7.6% | -43.3% |
| 净利率 | 5.6% | -82.0% |
| 营收同比 | 9.0% | -22.7% |
| 净利润同比 | -6.7% | -104.8% |
| 每股收益（稀释后） | $0.30 | $-1.63 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FORPTCT
| Q4 25 | $273.0M | $164.7M | ||
| Q3 25 | $670.5M | $211.0M | ||
| Q2 25 | $390.5M | $178.9M | ||
| Q1 25 | $351.0M | $1.2B | ||
| Q4 24 | $250.4M | $213.2M | ||
| Q3 24 | $551.3M | $196.8M | ||
| Q2 24 | $318.4M | $186.7M | ||
| Q1 24 | $333.8M | $210.1M |
净利润FORPTCT
| Q4 25 | $15.4M | $-135.0M | ||
| Q3 25 | $86.9M | $15.9M | ||
| Q2 25 | $32.9M | $-64.8M | ||
| Q1 25 | $31.6M | $866.6M | ||
| Q4 24 | $16.5M | $-65.9M | ||
| Q3 24 | $81.5M | $-106.7M | ||
| Q2 24 | $38.7M | $-99.2M | ||
| Q1 24 | $45.0M | $-91.6M |
毛利率FORPTCT
| Q4 25 | 20.1% | — | ||
| Q3 25 | 22.3% | — | ||
| Q2 25 | 20.4% | — | ||
| Q1 25 | 22.6% | — | ||
| Q4 24 | 22.0% | — | ||
| Q3 24 | 23.9% | — | ||
| Q2 24 | 22.5% | — | ||
| Q1 24 | 24.9% | — |
营业利润率FORPTCT
| Q4 25 | 7.6% | -43.3% | ||
| Q3 25 | 16.9% | 1.4% | ||
| Q2 25 | 11.2% | -19.5% | ||
| Q1 25 | 11.6% | 82.5% | ||
| Q4 24 | 8.7% | -76.2% | ||
| Q3 24 | 19.7% | -27.7% | ||
| Q2 24 | 16.2% | -21.5% | ||
| Q1 24 | 17.6% | -21.6% |
净利率FORPTCT
| Q4 25 | 5.6% | -82.0% | ||
| Q3 25 | 13.0% | 7.5% | ||
| Q2 25 | 8.4% | -36.3% | ||
| Q1 25 | 9.0% | 73.7% | ||
| Q4 24 | 6.6% | -30.9% | ||
| Q3 24 | 14.8% | -54.2% | ||
| Q2 24 | 12.2% | -53.1% | ||
| Q1 24 | 13.5% | -43.6% |
每股收益（稀释后）FORPTCT
| Q4 25 | $0.30 | $-1.63 | ||
| Q3 25 | $1.70 | $0.20 | ||
| Q2 25 | $0.65 | $-0.83 | ||
| Q1 25 | $0.62 | $10.04 | ||
| Q4 24 | $0.32 | $-0.85 | ||
| Q3 24 | $1.59 | $-1.39 | ||
| Q2 24 | $0.76 | $-1.29 | ||
| Q1 24 | $0.89 | $-1.20 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $211.7M | $1.9B |
| 总债务越低越好 | $793.2M | — |
| 股东权益账面价值 | $1.8B | $-205.3M |
| 总资产 | $3.2B | $2.9B |
| 负债/权益比越低杠杆越低 | 0.44× | — |
8季度趋势，按日历期对齐
现金及短期投资FORPTCT
| Q4 25 | $211.7M | $1.9B | ||
| Q3 25 | $379.2M | $1.7B | ||
| Q2 25 | $189.2M | $2.0B | ||
| Q1 25 | $174.3M | $2.0B | ||
| Q4 24 | $132.0M | $1.1B | ||
| Q3 24 | $481.2M | $1.0B | ||
| Q2 24 | $359.2M | $1.1B | ||
| Q1 24 | $416.2M | $884.8M |
总债务FORPTCT
| Q4 25 | $793.2M | — | ||
| Q3 25 | $802.7M | — | ||
| Q2 25 | $872.8M | — | ||
| Q1 25 | $872.5M | — | ||
| Q4 24 | $806.8M | — | ||
| Q3 24 | $706.4M | — | ||
| Q2 24 | $706.1M | — | ||
| Q1 24 | $705.7M | — |
股东权益FORPTCT
| Q4 25 | $1.8B | $-205.3M | ||
| Q3 25 | $1.8B | $-155.8M | ||
| Q2 25 | $1.7B | $-206.5M | ||
| Q1 25 | $1.6B | $-185.8M | ||
| Q4 24 | $1.6B | $-1.1B | ||
| Q3 24 | $1.6B | $-1.1B | ||
| Q2 24 | $1.5B | $-980.2M | ||
| Q1 24 | $1.5B | $-893.9M |
总资产FORPTCT
| Q4 25 | $3.2B | $2.9B | ||
| Q3 25 | $3.1B | $2.6B | ||
| Q2 25 | $3.1B | $2.6B | ||
| Q1 25 | $3.0B | $2.7B | ||
| Q4 24 | $3.0B | $1.7B | ||
| Q3 24 | $2.8B | $1.8B | ||
| Q2 24 | $2.7B | $1.9B | ||
| Q1 24 | $2.6B | $1.8B |
负债/权益比FORPTCT
| Q4 25 | 0.44× | — | ||
| Q3 25 | 0.45× | — | ||
| Q2 25 | 0.52× | — | ||
| Q1 25 | 0.53× | — | ||
| Q4 24 | 0.50× | — | ||
| Q3 24 | 0.44× | — | ||
| Q2 24 | 0.47× | — | ||
| Q1 24 | 0.48× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-157.0M | $-34.3M |
| 自由现金流经营现金流 - 资本支出 | $-157.1M | $-36.6M |
| 自由现金流率自由现金流/营收 | -57.5% | -22.3% |
| 资本支出强度资本支出/营收 | 0.0% | 1.4% |
| 现金转化率经营现金流/净利润 | -10.19× | — |
| 过去12个月自由现金流最近4个季度 | $93.0M | $702.3M |
8季度趋势，按日历期对齐
经营现金流FORPTCT
| Q4 25 | $-157.0M | $-34.3M | ||
| Q3 25 | $256.3M | $-66.3M | ||
| Q2 25 | $15.8M | $-58.3M | ||
| Q1 25 | $-19.8M | $870.1M | ||
| Q4 24 | $-450.0M | $-30.0M | ||
| Q3 24 | $119.2M | $-77.0M | ||
| Q2 24 | $-61.7M | $-71.5M | ||
| Q1 24 | $-59.2M | $70.8M |
自由现金流FORPTCT
| Q4 25 | $-157.1M | $-36.6M | ||
| Q3 25 | $255.6M | $-69.7M | ||
| Q2 25 | $15.0M | $-59.6M | ||
| Q1 25 | $-20.5M | $868.4M | ||
| Q4 24 | — | $-33.8M | ||
| Q3 24 | $118.4M | $-77.5M | ||
| Q2 24 | $-62.3M | $-78.8M | ||
| Q1 24 | $-59.8M | $61.2M |
自由现金流率FORPTCT
| Q4 25 | -57.5% | -22.3% | ||
| Q3 25 | 38.1% | -33.1% | ||
| Q2 25 | 3.8% | -33.3% | ||
| Q1 25 | -5.8% | 73.8% | ||
| Q4 24 | — | -15.8% | ||
| Q3 24 | 21.5% | -39.4% | ||
| Q2 24 | -19.6% | -42.2% | ||
| Q1 24 | -17.9% | 29.1% |
资本支出强度FORPTCT
| Q4 25 | 0.0% | 1.4% | ||
| Q3 25 | 0.1% | 1.6% | ||
| Q2 25 | 0.2% | 0.7% | ||
| Q1 25 | 0.2% | 0.1% | ||
| Q4 24 | 0.0% | 1.8% | ||
| Q3 24 | 0.1% | 0.3% | ||
| Q2 24 | 0.2% | 4.0% | ||
| Q1 24 | 0.2% | 4.6% |
现金转化率FORPTCT
| Q4 25 | -10.19× | — | ||
| Q3 25 | 2.95× | -4.17× | ||
| Q2 25 | 0.48× | — | ||
| Q1 25 | -0.63× | 1.00× | ||
| Q4 24 | -27.27× | — | ||
| Q3 24 | 1.46× | — | ||
| Q2 24 | -1.59× | — | ||
| Q1 24 | -1.32× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FOR
| D.R.Horton Inc. | $183.8M | 67% |
| Other | $89.2M | 33% |
PTCT
暂无分部数据
